Nutrition 21, LLC Presents the Effects of Velositol® On Muscle Protein Synthesis Signaling Factors at the International Society of Sports Nutrition’s 2018 Conference
Nutrition 21, LLC (“Nutrition 21”) is proud to announce the presentation of new preclinical study results demonstrating that Velositol®, a modified-release chromium complex combined with a specialized form of amylopectin, significantly enhances the activity of key signaling factors for muscle protein synthesis (MPS)
Nitrosigine®, Velositol®, nooLVL®, Lustriva™, Chromax®, Zinmax®, and their associated logos are registered trademarks of Nutrition21, LLC. All third party trademarks are the property of their respective owners. Nutrition21, LLC's products are protected by a number of patents including, but not limited to: US Patent Nos. 6,809,115; 6,803,456; 7,576,132; 8,062,677; 8,933,022; 9,005,637; 9,028,879; 9,119,835; 9,421,170; 9,597,404; 9,675,702; 10,183,049; 10,245,325; and 10,363,222.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.